Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 - Wiviott, SD; Braunwald, E; Angiolillo, DJ; TRITON-TIMI 38 Investigators (Circulation, 2008)